Literature DB >> 31076319

Bloodstream infection with extended-spectrum beta-lactamase-producing Escherichia coli: The role of virulence genes.

Wan-Ting Hung1, Ming-Fang Cheng2, Fan-Chen Tseng3, Yao-Shen Chen4, Susan Shin-Jung Lee5, Tsung-Hsien Chang6, Hsi-Hsun Lin7, Chih-Hsin Hung8, Jiun-Ling Wang9.   

Abstract

BACKGROUND: Extraintestinal pathogenic Escherichia coli (ExPEC) strains hold the responsibility for the majority of E. coli infections. Numerous extraintestinal virulence factors (VFs) were possessed by ExPEC which are involved in the pathogenesis of infection. However, the effect of comorbidities or infection syndrome in the association of VFs and mortality remains inconclusive.
METHOD: This study addressed whether specific sequence type (ST) and VFs of extended-spectrum beta-lactamase-producing E. coli (ESBL-EC) are associated with different outcomes in patients with bloodstream infection. 121 adults from southern Taiwan with ESBL-EC bloodstream infections were enrolled during a 6-year period. Demographic data, including infection syndromes, underlying disease and outcomes, were collected. The virulence factors in isolates were analyzed by PCR and multilocus sequence typing analyses were also performed. RESULT: Positivity for the virulence genes iha, hlyD, sat, iutA, fyuA, malX, ompT, and traT was associated with ST131 positivity (P < 0.05). Some ESBL-EC virulence genes associated with urinary tract infection (UTI) were revealed. Positivity for ST405 and the virulence genes iroN and iss were significantly associated with increased 30-day mortality (death within 30 days) on univariate analysis (P < 0.05). Independent risk factors of 30-day mortality in bacteremic patients with UTI included underlying chronic liver disease and malignancy. ST131 was borderline associated with 30-day mortality. Independent risk factors associated with 30-day mortality among bacteremic patients without UTI included comorbidities and iroN positivity.
CONCLUSION: In bacteremic patients with UTI, and the ST131 clone was borderline associated with mortality. Positivity for the virulence gene iroN may be linked to mortality in bacteremic patients without UTI.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31076319     DOI: 10.1016/j.jmii.2019.03.005

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  9 in total

1.  Extended-Spectrum-β-Lactamase- and Plasmid AmpC-Producing Escherichia coli Causing Community-Onset Bloodstream Infection: Association of Bacterial Clones and Virulence Genes with Septic Shock, Source of Infection, and Recurrence.

Authors:  Inga Fröding; Badrul Hasan; Isak Sylvin; Maarten Coorens; Pontus Nauclér; Christian G Giske
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

2.  Escherichia coli Sequence Type 457 Is an Emerging Extended-Spectrum-β-Lactam-Resistant Lineage with Reservoirs in Wildlife and Food-Producing Animals.

Authors:  Steven P Djordjevic; Monika Dolejska; Kristina Nesporova; Ethan R Wyrsch; Adam Valcek; Ibrahim Bitar; Khin Chaw; Patrick Harris; Jaroslav Hrabak; Ivan Literak
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

3.  Characterization of Beta-Lactamases in Bloodstream-Infection Escherichia coli: Dissemination of blaADC - 162 and blaCMY- 2 Among Bacteria via an IncF Plasmid.

Authors:  Linlin Xiao; Xiaotong Wang; Nana Kong; Long Zhang; Mei Cao; Muzhen Sun; Quhao Wei; Weiwei Liu
Journal:  Front Microbiol       Date:  2019-10-01       Impact factor: 5.640

4.  Phylogeny, Resistome, and Virulome of Escherichia coli Causing Biliary Tract Infections.

Authors:  Ángel Rodríguez-Villodres; Rémy A Bonnin; José Manuel Ortiz de la Rosa; Rocío Álvarez-Marín; Thierry Naas; Javier Aznar; Jerónimo Pachón; José Antonio Lepe; Younes Smani
Journal:  J Clin Med       Date:  2019-12-02       Impact factor: 4.241

5.  Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Patients with Liver Cirrhosis.

Authors:  Wen-Chi Chen; Chih-Hsin Hung; Yao-Shen Chen; Jin-Shiung Cheng; Susan Shin-Jung Lee; Fan-Chen Tseng; Ming-Fang Cheng; Jiun-Ling Wang
Journal:  Pathogens       Date:  2021-01-05

6.  Clinical Impact and Risk Factors of Nonsusceptibility to Third-Generation Cephalosporins Among Hospitalized Adults with Monomicrobial Enterobacteriaceae Bacteremia in Southern Taiwan: A Multicenter Study.

Authors:  Tsao-Chin Lin; Yuan-Pin Hung; Ching-Chi Lee; Wei-Tang Lin; Li-Chen Huang; Wei Dai; Chi-Shuang Kuo; Wen-Chien Ko; Yeou-Lih Huang
Journal:  Infect Drug Resist       Date:  2021-02-24       Impact factor: 4.003

7.  Multi-Drug Resistant Plasmids with ESBL/AmpC and mcr-5.1 in Paraguayan Poultry Farms: The Linkage of Antibiotic Resistance and Hatcheries.

Authors:  Kristina Nesporova; Adam Valcek; Costas Papagiannitsis; Iva Kutilova; Ivana Jamborova; Lenka Davidova-Gerzova; Ibrahim Bitar; Jaroslav Hrabak; Ivan Literak; Monika Dolejska
Journal:  Microorganisms       Date:  2021-04-17

8.  Secreted Autotransporter Toxin (Sat) Mediates Innate Immune System Evasion.

Authors:  Claudia A Freire; Rosa M Silva; Rita C Ruiz; Daniel C Pimenta; Jack A Bryant; Ian R Henderson; Angela S Barbosa; Waldir P Elias
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

9.  A retrospective study on Escherichia coli bacteremia in immunocompromised patients: Microbiological features, clinical characteristics, and risk factors for shock and death.

Authors:  Xiaoyan Tao; Haichen Wang; Changhang Min; Ting Yu; Yi Luo; Jun Li; Yongmei Hu; Qun Yan; Wen' En Liu; Mingxiang Zou
Journal:  J Clin Lab Anal       Date:  2020-04-08       Impact factor: 2.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.